1077MO PD1 blockade with pembrolizumab in classic and endemic Kaposi sarcoma: A multicenter phase II study. - Delyon, J.; Resche-Rigon, M.; Renaud, M.; Le Goff, J.; Dalle, S.; Heidelberger, V.; Da Meda, L.; Allain, V.; Toullec, L.; Carcelain, G.; Mourah, S.; Caillat-Zucman, S.; et al. (Annals of Oncology, 2020)